Clinical trial
Mechanistic Study of Histidine-mediated Regulation of Antigen Presentation in Colorectal Cancer to Enhance Sensitivity to Immunotherapy
NCT07586293 is registered in ClinicalTrials.gov with Jing-yuan Fang, MD, Ph. D as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mechanistic Study of Histidine-mediated Regulation of Antigen Presentation in Colorectal Cancer to Enhance Sensitivity to Immunotherapy
- Lead sponsor
- Jing-yuan Fang, MD, Ph. D
- Phase
- Observational
- Overall status
- Not yet recruiting
- Start date
- May 31, 2026
- Completion date
- June 30, 2027
- Enrollment
- 150 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
colorectal cancer